Effects of long-acting methylphenidate in adults with attention deficit hyperactivity disorder: A study with paired-pulse transcranial magnetic stimulation

Neuropsychobiology

Volumn 64, Issue 4, 2011, Pages 195-201

  Schneider, Marc K F ^a,c   Retz, Wolfgang ^a   Gougleris, Gavril ^b   Verhoeven, Willem M A ^c,d   Tulen, Joke H M ^d   Rösler, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SHG Clinic for Psychiatry   (Germany)

^c VINCENT VAN GOGH INSTITUTE FOR PSYCHIATRY   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Attention deficit hyperactivity disorder, adults; Methylphenidate; Paired pulse transcranial magnetic stimulation

Indexed keywords

METHYLPHENIDATE;

ADULT; AMPLITUDE MODULATION; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EVOKED CORTICAL RESPONSE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CEREBRAL CORTEX; COMBINED MODALITY THERAPY; DELAYED-ACTION PREPARATIONS; EVOKED POTENTIALS; FEMALE; HUMANS; MALE; METHYLPHENIDATE; MIDDLE AGED; NEURAL INHIBITION; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 80052697847     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000326693     Document Type: Article

References (43)

1. Heal DJ, Cheetham SC, Smith SL: The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety. Neuropharmacology 2009; 57: 608-618.
2. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B, Hamilton C, Spencer RC: Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 2006; 60: 1111-1120. (Pubitemid 44647216)
3. Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH, Gabrieli JD: Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study. Proc Natl Acad Sci USA 1998; 95: 14494-14499. (Pubitemid 28549395)
4. Bush G, Spencer TJ, Holmes J, Shin LM, Valera EM, Seidman LJ, Makris N, Surman C, Aleardi M, Mick E, Biederman J: Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Arch Gen Psychiatry 2008; 65: 102-114.
5. Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, Wroe S, Asselman P, Marsden CD: Corticocortical inhibition in human motor cortex. J Physiol 1993; 471: 501-519. (Pubitemid 23345592)
6. Ziemann U: TMS and drugs. Clin Neurophysiol 2004; 115: 1717-1729. (Pubitemid 38952939)
7. Buchmann J, Gierow W, Weber S, Hoeppner J, Klauer T, Benecke R, Haessler F, Wolters A: Restoration of disturbed intracortical motor inhibition and facilitation in attention deficit hyperactivity disorder children by methylphenidate. Biol Psychiatry 2007; 62: 963-969. (Pubitemid 47562374)
8. Gilbert DL, Ridel KR, Sallee FR, Zhang J, Lipps TD, Wassermann EM: Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex. Neuropsychopharmacology 2006; 31: 442-449. (Pubitemid 43113408)
9. Hoeppner J, Neumeyer M, Wandschneider R, Herpertz SC, Gierow W, Haessler F, Buchmann J: Intracortical motor inhibition and facilitation in adults with attention deficit/hyperactivity disorder. J Neural Transm 2008; 115: 1701-1707.
10. Ilic TV, Korchounov A, Ziemann U: Methylphenidate facilitates and disinhibits the motor cortex in intact humans. Neuroreport 2003; 14: 773-776. (Pubitemid 36570940)
11. Moll GH, Heinrich H, Trott G, Wirth S, Rothenberger A: Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate. Neurosci Lett 2000; 284: 121-125. (Pubitemid 30193214)
12. Moll GH, Heinrich H, Rothenberger A: Methylphenidate and intracortical excitability: Opposite effects in healthy subjects and attention-deficit hyperactivity disorder. Acta Psychiatr Scand 2003; 107: 69-72. (Pubitemid 36092247)
13. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer T: A randomized, placebo-controlled trial of OROS methylphenidate in adults with attentiondeficit/hyperactivity disorder. Biol Psychiatry 2006; 59: 829-835.
14. Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E: Long-acting medications for the treatment of hyperkinetic disorders -a systematic review and European treatment guideline. Part 1: Overview and recommendations. Z Kinder Jugendpsychiatr Psychother 2008; 36: 81-94.
15. Rösler M, Retz W, Retz-Junginger P, Thome J, Supprian T, Nissen T, Stieglitz RD, Blocher D, Hengesch G, Trott GE: Tools for the diagnosis of attention-deficit/hyperactivity disorder in adults. Self-rating behaviour questionnaire and diagnostic checklist. Nervenarzt 2004; 75: 888-895. (Pubitemid 39312514)
16. Retz-Junginger P, Retz W, Blocher D, Weijers HG, Trott GE, Wender PH, Rösler M: Wender Utah Rating Scale: The short version for the assessment of the attention deficit hyperactivity disorder in adults. Nervenarzt 2002; 73: 830-838. (Pubitemid 36062318)
17. Retz-Junginger P, Retz W, Blocher D, Stieglitz RD, Georg T, Supprian T, Wender PH, Rösler M: Reliability and validity of the Wender-Utah-Rating- Scale short form: Retrospective assessment of symptoms for attention deficit/hyperactivity disorder. Nervenarzt 2003; 74: 987-993. (Pubitemid 37442506)
18. Rösler M, Retz W, Retz-Junginger P, Stieglitz RD, Kessler H, Reimherr F, Wender PH: Attention deficit hyperactivity disorder in adults: Benchmarking diagnosis using the Wender-Reimherr adult rating scale. Nervenarzt 2008; 79: 320-327.
19. Wender PH: Attention-Deficit Hyperactivity Disorder in Adults. New York, Oxford University Press, 1995.
20. Lehrl S: Mehrfachwahl Wortschatztest MWT-B. Erlangen, Perimed Verlag, 1975.
21. Maeda F, Gangitano M, Thall M, Pascual-Leone A: Inter-and intra-individual variability of paired-pulse curves with transcranial magnetic stimulation (TMS). Clin Neurophysiol 2002; 113: 376-382. (Pubitemid 34233859)
22. Schneider M, Retz W, Freitag C, Irsch J, Graf P, Retz-Junginger P, Rösler M: Impaired cortical inhibition in adult ADHD patients: A study with transcranial magnetic stimulation. J Neural Transm Suppl 2007; 72: 303-309.
23. Richter MM, Ehlis A-C, Bähne C-B, Scheuerpflug P, Jacob CP, Fallgatter AJ: Inhibitory brain functions in adult ADHD patients. Nervenheilkunde 2006; 25: 657-661. (Pubitemid 46173384)
24. Richter MM, Ehlis A-C, Jacob CP, Fallgatter AJ: Cortical excitability in adult patients with attention-deficit/hyperactivity disorder (ADHD). Neurosci Lett 2007; 419: 137-141. (Pubitemid 46719659)
25. Ziemann U, Rothwell JC, Ridding MC: Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol 1996; 496: 873-881. (Pubitemid 26387868)
26. Kirschner J, Moll GH, Fietzek UM, Heinrich H, Mall V, Berweck S, Heinen F, Rothenberger A: Methylphenidate enhances both intracortical inhibition and facilitation in healthy adults. Pharmacopsychiatry 2003; 36: 79-82. (Pubitemid 36609514)
27. Wassermann EM, Samii A, Mercuri B, Ikoma K, Oddo D, Grill SE, Hallett M: Responses to paired transcranial magnetic stimuli in resting, active, and recently activated muscles. Exp Brain Res 1996; 109: 158-163. (Pubitemid 26119977)
28. Ziemann U, Tergau F, Wischer S, Hildebrandt J, Paulus W: Pharmacological control of facilitatory I-wave interaction in the human motor cortex: A paired transcranial magnetic stimulation study. Electroencephalogr Clin Neurophysiol 1998; 109: 321-330.
29. Gerdelat-Mas A, Loubinoux I, Tombari D, Rascol O, Chollet F, Simonetta-Moreau M: Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects. Neuroimage 2005; 27: 314-322. (Pubitemid 41074834)
30. Eichhammer P, Langguth B, Wiegand R, Kharraz A, Frick U, Hajak G: Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonintransporter reuptake inhibitor (SSRI). Psychopharmacology 2003; 166: 294-297. (Pubitemid 36384777)
31. Volz TJ: Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate. Curr Neuropharmacol 2008; 6: 379-385.
32. Markowitz JS, DeVane CL, Pestreich LK, Patrick KS, Muniz R: A comprehensive in vitro screening of d -, l -, and dl -threo-methylphenidate: An exploratory study. J Child Adolesc Psychopharmacol 2006; 16: 687-698. (Pubitemid 46175425)
33. Inghilleri M, Berardelli A, Marchetti P, Manfredi M: Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans. Exp Brain Res 1996; 109: 467-472. (Pubitemid 26188638)
34. Werhahn KJ, Kunesch E, Noachtar S, Benecke R, Classen J: Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol 1999; 517: 591-597. (Pubitemid 29296371)
35. Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W: Effects of antiepileptic drugs on motor cortex excitability in humans: A transcranial magnetic stimulation study. Ann Neurol 1996; 40: 367-378. (Pubitemid 26304794)
36. Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W: The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res 1996; 109: 127-135. (Pubitemid 26119972)
37. Solanto MV: Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration. Behav Brain Res 1998; 94: 127-152. (Pubitemid 28352470)
38. Moll GH, Heinrich H, Rothenberger A: Transcranial magnetic stimulation in child and adolescent psychiatry: Excitability of the motor system in tic disorders and/or attention deficit hyperactivity disorders. Z Kinder Jugendpsychiatr Psychother 2001; 29: 312-323. (Pubitemid 33081358)
39. Barkley RA: Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychol Bull 1997; 121: 65-94. (Pubitemid 127705285)
40. Sagvolden T, Sergeant JA: Attention deficit/hyperactivity disorder: From brain dysfunctions to behaviour. Behav Brain Res 1998; 94: 1-10. (Pubitemid 28352459)
41. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, Hitzemann R, Pappas N: Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 1998; 155: 1325-1331. (Pubitemid 28471187)
42. Lou HC, Henriksen L, Bruhn P: Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Arch Neurol 1984; 41: 825-829. (Pubitemid 14091724)
43. Biederman J, Mick E, Faraone SV: Age-dependent decline of symptoms of attention deficit hyperactivity disorder: Impact of remission definition and symptom type. Am J Psychiatry 2000; 157: 816-818. (Pubitemid 30249663)